Vincent Vultaggio is Principal Accounting Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 33,855 shares of ZNTL, which is worth approximately $118,492. The most recent transaction as insider was on Oct 04, 2024, when has been sold 1,603 shares (Common Stock) at a price of $3.18 per share, resulting in proceeds of $5,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.9K
n/a 3M change
n/a 12M change
Total Value Held $118,492

Vincent Vultaggio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 04 2024
SELL
Open market or private sale
$5,097 $3.18 p/Share
1,603 Reduced 4.52%
33,855 Common Stock
VV

Vincent Vultaggio

Principal Accounting Officer
San Diego, CA

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL